Malignant Genitourinary System Neoplasm

Malignant Genitourinary System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

15,544 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3,549
Recruiting: 1,935
Ph III recruiting: 225
Growth YoY: +16.5%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,963)

clinicaltrialsPublishedShowing 301–350 of 4,525 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06205316	SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma	active not recruiting	Phase 3	118	Mayo ClinicOTHER	1	Sep 17, 2026	clinicaltrials
NCT06340568	A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer(Fern-EC-01)	recruiting	Phase 3	480	BioNTech SEINDUSTRY	26	Sep 17, 2026